The future of infectious disease diagnostics starts at Day Zero. By using whole-genome sequencing (WGS) and our proprietary enabling technologies, Day Zero is creating a new class of sequencing-based in-vitro diagnostics that generates clinically actionable data at scale. Our technologies include novel sample preparation methods enabling unprecedented ultra-high enrichment of pathogen DNA for sequencing directly from clinical samples, machine learning algorithms that provide clinically actionable diagnostic results, and a world-class database of WGS and drug efficacy profiles. Day Zero Diagnostics is on a mission to transform the way infectious disease diagnostics are performed by generating the stream of real-time sequencing data required to change how we track, manage and combat infectious diseases.
With an enormous unmet clinical and economic need, we are targeting bloodstream infections and sepsis for our first application. The life expectancy of a patient with septic shock is 24 hours without fast effective antibiotic treatment. However, even when successful, current diagnostics take 2-5 days to identify the pathogen AND provide its antibiotic susceptibility profile. The lack of rapid, accurate, and comprehensive diagnostics, forces physicians to “carpet bomb” patients with severe infections with powerful, yet toxic, broad-spectrum antibiotics, which is not only ineffective in many cases but can also lead to significant morbidity and mortality. Day Zero delivers a complete diagnosis, including both the species and antibiotic resistance profile, in hours vs. days, enabling the physician to use a targeted treatment on day zero of hospital admission and resulting in better patient outcomes and cost savings.
Location: United States, Massachusetts, Boston
Employees: 11-50
Total raised: $60M
Founded date: 2016
Founders name: Jong Lee
Founders Related Locations: Cambridge, MA
Investors 4
Date | Name | Website |
- | MassChalle... | masschalle... |
- | Triventure... | triventure... |
- | HealthTech... | healthtech... |
- | CARB-X | carb-x.org |
Funding Rounds 5
Date | Series | Amount | Investors | Deal News |
22.09.2023 | - | $16M | - | finsmes.co... |
24.10.2022 | - | $8.2M | CARB-X | massdevice... |
09.02.2022 | - | $21M | - | finsmes.co... |
11.05.2020 | - | $6.2M | - | bizjournal... |
23.01.2019 | Series A | $8.6M | - | finsmes.co... |
Mentions in press and media 21
Date | Title | Description | Source |
11.10.2023 | HealthTech Arkansas Cohort Companies in the News | 2022 cohort company Echo IQ has partnered with Cassling, a company that will act as a sales agent fo... | healthtech... |
22.09.2023 | Day Zero Diagnostics Closes $16M Financing Round | Day Zero Diagnostics Inc., a Boston, MA-based infectious disease diagnostics company leveraging whol... | finsmes.co... |
20.09.2023 | Day Zero Diagnostics completes $16M funding round | Day Zero Diagnostics — which seeks to harness whole-genome sequencing and AI in the fight against an... | massdevice... |
24.10.2022 | Day Zero Diagnostics raises $8.2M from CARB-X | Day Zero Diagnostics announced that it received an $8.2 million award in optional stage funding from... | massdevice... |
11.04.2022 | Day Zero Diagnostics Announces the Launch of Day Zero Lab Se... | BOSTON (PRWEB) April 11, 2022 Day Zero Diagnostics, Inc., an infectious disease diagnostics company... | prweb.com/... |
15.02.2022 | Day Zero Diagnostics Closes $21M Financing | Day Zero Diagnostics, a Boston, MA-based infectious disease diagnostics company, raised $21M in fund... | finsmes.co... |
11.02.2022 | Genomics + machine learning = company's strategy to speed up... | Day Zero Diagnostics has been focused on combining genome sequencing and machine learning to diagnos... | endpts.com... |
10.02.2022 | BD joins Day Zero's $21M fundraising for sequencing-based in... | A recent analysis showing that antibiotic-resistant infections were responsible for at least 1.2 mil... | fiercebiot... |
10.02.2022 | BD joins Day Zero’s $21M fundraising for sequencing-based in... | A recent analysis showing that antibiotic-resistant infections were responsible for at least 1.2 mil... | fiercebiot... |
09.02.2022 | Day Zero Diagnostics raises $21M | Infectious disease diagnostic company Day Zero Diagnostics announced today that it completed a ventu... | massdevice... |
Show more